Suspension of trading

Income Statement Monogram Technologies Inc.

Stocks

MGRM

US6097861081

Medical Equipment, Supplies & Distribution

Delayed Nasdaq Other stock markets 21:00:00 06/10/2025 BST			5-day change	1st Jan Change
6.000 ^USD	-1.80%		-.--%	-

08/10/25	Zimmer Biomet Wraps Up Purchase of Orthopedic Robotics Group Monogram Technologies	MT
08/10/25	Monogram Technologies Inc.(NasdaqCM:MGRM) dropped from S&P TMI Index	CI

fe334b60.x3ZdSX66IA8kFOdWIjTxnKgwiHDvins7s_8HWMv_OhI._i4LKDXXZ0JKQaUacUKF9PB0sD6D3hFZ2pQzYJvPaF73Ny0LP8laWVVa1w

Published financial data: MONOGRAM TECHNOLOGIES INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	-	628K	-	365K	-
Total Revenues	-	628K	-	365K	-
Cost of Goods Sold, Total	-	459K	-	-	-
Gross Profit	-	170K	-	365K	-
Selling General & Admin Expenses, Total	2.99M	5.17M	5.64M	7.05M	6.52M
Stock-Based Compensation (IS)	2.16M	-	-	-	-
R&D Expenses	1.6M	5.28M	4.97M	10.59M	8.79M
Depreciation & Amortization - (IS)	95.69K	-	-	-	-
Other Operating Expenses, Total	6.85M	10.45M	10.61M	17.63M	15.31M
Operating Income	-6.85M	-10.28M	-10.61M	-17.27M	-15.31M
Interest Expense, Total	-54.25K	-21.66K	-	-	-
Interest And Investment Income	45.93K	47.77K	98.06K	434K	526K
Net Interest Expenses	-8.32K	26.11K	98.06K	434K	526K
Other Non Operating Income (Expenses)	-2.21M	-1.56M	-3.18M	3.09M	-1.54M
EBT, Excl. Unusual Items	-9.07M	-11.81M	-13.69M	-13.75M	-16.33M
EBT, Incl. Unusual Items	-9.07M	-11.81M	-13.69M	-13.75M	-16.33M
Earnings From Continuing Operations	-9.07M	-11.81M	-13.69M	-13.75M	-16.33M
Net Income to Company	-9.07M	-11.81M	-13.69M	-13.75M	-16.33M
Net Income - (IS)	-9.07M	-11.81M	-13.69M	-13.75M	-16.33M
Net Income to Common Incl Extra Items	-9.07M	-11.81M	-13.69M	-13.75M	-16.33M
Net Income to Common Excl. Extra Items	-9.07M	-11.81M	-13.69M	-13.75M	-16.33M
Per Share Items
Net EPS - Basic	-0.99	-1.22	-1.42	-0.61	-0.5
Basic EPS - Continuing Operations	-0.99	-1.22	-1.42	-0.61	-0.5
Basic Weighted Average Shares Outstanding	9.13M	9.67M	9.67M	22.41M	32.57M
Net EPS - Diluted	-0.99	-1.22	-1.42	-0.61	-0.5
Diluted EPS - Continuing Operations	-0.99	-1.22	-1.42	-0.61	-0.5
Diluted Weighted Average Shares Outstanding	9.13M	9.67M	9.67M	22.41M	32.57M
Normalized Basic EPS	-0.62	-0.76	-0.88	-0.38	-0.31
Normalized Diluted EPS	-0.62	-0.76	-0.88	-0.38	-0.31
Supplemental Items
EBITDA	-6.76M	-9.96M	-10.23M	-16.86M	-14.88M
EBITA	-6.85M	-10.12M	-10.4M	-17.06M	-15.1M
EBIT	-6.85M	-10.28M	-10.61M	-17.27M	-15.31M
EBITDAR	-6.67M	-9.85M	-10.09M	-16.72M	-14.74M
Normalized Net Income	-5.67M	-7.38M	-8.56M	-8.59M	-10.2M
Interest on Long-Term Debt	54.25K	-	-	-	-
Supplemental Operating Expense Items
Marketing Expenses	1.18M	3.27M	2.71M	2.99M	2.1M
Selling and Marketing Expenses	1.18M	3.27M	2.71M	2.99M	2.11M
General and Administrative Expenses	663K	1.9M	2.93M	4.05M	4.41M
Research And Development Expense From Footnotes	1.6M	5.28M	4.97M	10.59M	8.79M
Net Rental Expense, Total	80.76K	103K	135K	141K	136K
Imputed Operating Lease Interest Expense	30.09K	85.4K	-	-	-
Imputed Operating Lease Depreciation	50.67K	17.34K	-	-	-
Stock-Based Comp., R&D Exp. (Total)	-	-	-	-	701K
Stock-Based Comp., S&M Exp. (Total)	-	-	-	-	12K
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	460K
Stock-Based Comp., Other (Total)	2.16M	206K	743K	1.56M	1K
Total Stock-Based Compensation	2.16M	206K	743K	1.56M	1.17M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	5.59M	5.54M	10.47M	13.59M	15.66M
Short Term Investments	-	-	-	-	32K
Total Cash And Short Term Investments	5.59M	5.54M	10.47M	13.59M	15.69M
Accounts Receivable, Total	-	-	-	365K	-
Other Receivables	-	419K	158K	-	-
Total Receivables	-	419K	158K	365K	-
Inventory	-	-	4.55K	-	288K
Prepaid Expenses	841K	309K	376K	-	-
Other Current Assets, Total	-	250K	250K	664K	305K
Total Current Assets	6.43M	6.51M	11.26M	14.62M	16.28M
Gross Property Plant And Equipment	1.7M	1.56M	2.18M	2.12M	2.08M
Accumulated Depreciation	-172K	-328K	-505K	-707K	-927K
Net Property Plant And Equipment	1.53M	1.23M	1.67M	1.41M	1.15M
Other Intangibles, Total	150K	969K	759K	549K	339K
Other Long-Term Assets, Total	11.14K	-	-	-	-
Total Assets	8.12M	8.72M	13.69M	16.58M	17.77M
Liabilities
Accounts Payable, Total	183K	449K	663K	2.46M	1.17M
Accrued Expenses, Total	214K	464K	748K	228K	229K
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	57.54K	92.89K	118K	128K	138K
Other Current Liabilities	2.52M	4.09M	7.52M	-	-
Total Current Liabilities	2.98M	5.09M	9.05M	2.82M	1.54M
Long-Term Debt	-	-	-	-	-
Long-Term Leases	148K	119K	492K	364K	226K
Other Non Current Liabilities	-	-	1	-	1.5M
Total Liabilities	3.13M	5.21M	9.54M	3.18M	3.27M
Preferred Stock Convertible	4.9K	6.64K	8.53K	-	4K
Total Preferred Equity	4.9K	6.64K	8.53K	-	4K
Common Stock, Total	4.84K	4.84K	9.67K	31.34K	35K
Additional Paid In Capital	17.24M	27.56M	41.89M	64.87M	82.45M
Retained Earnings	-12.26M	-24.07M	-37.76M	-51.51M	-67.99M
Total Common Equity	4.98M	3.5M	4.14M	13.4M	14.5M
Total Equity	4.99M	3.5M	4.15M	13.4M	14.5M
Total Liabilities And Equity	8.12M	8.72M	13.69M	16.58M	17.77M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	9.67M	9.67M	9.67M	31.63M	35.29M
ECS Total Common Shares Outstanding	9.67M	9.67M	9.67M	31.34M	35.17M
Book Value / Share	0.52	0.36	0.43	0.43	0.41
Tangible Book Value	4.83M	2.53M	3.38M	12.85M	14.16M
Tangible Book Value Per Share	0.5	0.26	0.35	0.41	0.4
Total Debt	205K	211K	610K	492K	364K
Net Debt	-5.38M	-5.32M	-9.86M	-13.1M	-15.33M
Debt Equivalent Oper. Leases	646K	822K	1.08M	1.13M	1.09M
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	702K	808K	1.05M	1.11M	1.2M
Full Time Employees	18	20	27	28	27
Part Time Employees	-	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-9.07M	-11.81M	-13.69M	-13.75M	-16.33M
Depreciation & Amortization - CF	95.69K	166K	177K	202K	220K
Amortization of Goodwill and Intangible Assets - (CF)	-	156K	210K	210K	210K
Depreciation & Amortization, Total	95.69K	322K	387K	412K	430K
Stock-Based Compensation (CF)	2.16M	206K	743K	1.56M	1.17M
Other Operating Activities, Total	2.22M	1.56M	3.43M	-2.91M	1.6M
Change In Accounts Receivable	-	-	-	-365K	365K
Change In Accounts Payable	-59.04K	266K	214K	1.8M	-1.29M
Change in Other Net Operating Assets	-752K	290K	495K	-288K	85K
Cash from Operations	-5.4M	-9.17M	-8.42M	-13.54M	-13.97M
Capital Expenditure	-1.18M	-31.11K	-241K	-64.91K	-84K
Sale (Purchase) of Intangible assets	-150K	-975K	-	-	-
Cash from Investing	-1.33M	-1.01M	-241K	-64.91K	-84K
Long-Term Debt Issued, Total	79.02K	-	-	-	-
Total Debt Issued	79.02K	-	-	-	-
Long-Term Debt Repaid, Total	-840K	-	-	-	-
Total Debt Repaid	-840K	-	-	-	-
Issuance of Common Stock	-	-	-	16.58M	5.19M
Repurchase of Common Stock	-	-	-	-	-200K
Issuance of Preferred Stock	10.77M	10.12M	13.59M	147K	11.13M
Cash from Financing	10.01M	10.12M	13.59M	16.73M	16.12M
Net Change in Cash	3.27M	-51.04K	4.93M	3.12M	2.07M
Supplemental Items
Cash Interest Paid	144K	-	-	-	-
Levered Free Cash Flow	-2.02M	-4.97M	-1.62M	-15.37M	-8.9M
Unlevered Free Cash Flow	-1.98M	-4.96M	-1.62M	-15.37M	-8.9M
Change In Net Working Capital	-1.37M	-1.94M	-4.12M	6.48M	852K
Net Debt Issued / Repaid	-761K	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-79.76	-76.33	-59.21	-71.31	-55.71
Return on Total Capital	-121.57	-144.19	-156.56	-115.75	-66.55
Return On Equity %	-384.66	-278.24	-357.82	-156.67	-117.05
Return on Common Equity	-385.12	-278.62	-358.54	-156.75	-117.07
Margin Analysis
Gross Profit Margin %	-	26.99	-	100	-
SG&A Margin	-	822.68	-	1.93K	-
EBITDA Margin %	-	-1.58K	-	-4.62K	-
EBITA Margin %	-	-1.61K	-	-4.67K	-
EBIT Margin %	-	-1.64K	-	-4.73K	-
Income From Continuing Operations Margin %	-	-1.88K	-	-3.77K	-
Net Income Margin %	-	-1.88K	-	-3.77K	-
Net Avail. For Common Margin %	-	-1.88K	-	-3.77K	-
Normalized Net Income Margin	-	-1.18K	-	-2.35K	-
Levered Free Cash Flow Margin	-	-791.54	-	-4.21K	-
Unlevered Free Cash Flow Margin	-	-789.39	-	-4.21K	-
Asset Turnover
Asset Turnover	-	0.07	-	0.02	-
Fixed Assets Turnover	-	0.46	-	0.24	-
Short Term Liquidity
Current Ratio	2.16	1.28	1.24	5.19	10.57
Quick Ratio	1.88	1.17	1.17	4.95	10.18
Operating Cash Flow to Current Liabilities	-1.81	-1.8	-0.93	-4.81	-9.06
Average Days Payable Outstanding	-	251.4	-	-	-
Long Term Solvency
Total Debt/Equity	4.12	6.04	14.71	3.67	2.51
Total Debt / Total Capital	3.96	5.69	12.82	3.54	2.45
LT Debt/Equity	2.97	3.38	11.86	2.71	1.56
Long-Term Debt / Total Capital	2.85	3.19	10.34	2.62	1.52
Total Liabilities / Total Assets	38.52	59.8	69.69	19.19	18.38
EBIT / Interest Expense	-126.28	-474.48	-	-	-
EBITDA / Interest Expense	-123.03	-454.87	-	-	-
(EBITDA - Capex) / Interest Expense	-144.86	-456.3	-	-	-
Total Debt / EBITDA	-0.03	-0.02	-0.06	-0.03	-0.02
Net Debt / EBITDA	0.81	0.54	0.98	0.78	1.04
Total Debt / (EBITDA - Capex)	-0.03	-0.02	-0.06	-0.03	-0.02
Net Debt / (EBITDA - Capex)	0.68	0.54	0.95	0.78	1.03
Growth Over Prior Year
EBITDA, 1 Yr. Growth %	310.66	47.38	2.72	64.82	-11.72
EBITA, 1 Yr. Growth %	308.59	47.74	2.78	63.97	-11.48
EBIT, 1 Yr. Growth %	308.59	50.02	3.26	62.7	-11.34
Earnings From Cont. Operations, 1 Yr. Growth %	404.83	30.29	15.88	0.4	18.79
Net Income, 1 Yr. Growth %	404.83	30.29	15.88	0.4	18.79
Normalized Net Income, 1 Yr. Growth %	404.83	30.29	15.88	0.4	18.79
Diluted EPS Before Extra, 1 Yr. Growth %	220.21	22.99	15.88	-56.66	-18.27
Net Property, Plant and Equip., 1 Yr. Growth %	547.79	-19.26	35.82	-15.69	-18.7
Total Assets, 1 Yr. Growth %	209.75	7.39	57.08	21.1	7.18
Tangible Book Value, 1 Yr. Growth %	-1.86K	-47.71	33.79	279.91	10.22
Common Equity, 1 Yr. Growth %	-1.91K	-29.85	18.42	223.55	8.23
Cash From Operations, 1 Yr. Growth %	415.47	69.65	-8.16	60.85	3.14
Capital Expenditures, 1 Yr. Growth %	21.97K	-97.37	675.4	-73.09	29.23
Levered Free Cash Flow, 1 Yr. Growth %	898.13	146.68	-67.24	846	-42.08
Unlevered Free Cash Flow, 1 Yr. Growth %	1.5K	150.22	-67.24	846	-42.08
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	-	-23.78	-
Gross Profit, 2 Yr. CAGR %	-	-	-	46.71	-
EBITDA, 2 Yr. CAGR %	230.3	146.01	23.04	30.12	20.63
EBITA, 2 Yr. CAGR %	224.62	145.69	23.23	29.82	20.48
EBIT, 2 Yr. CAGR %	224.62	147.58	24.47	29.62	20.11
Earnings From Cont. Operations, 2 Yr. CAGR %	256.81	156.47	22.87	7.86	9.21
Net Income, 2 Yr. CAGR %	256.81	156.47	22.87	7.86	9.21
Normalized Net Income, 2 Yr. CAGR %	256.81	156.47	22.87	7.86	9.21
Diluted EPS Before Extra, 2 Yr. CAGR %	-46.32	98.45	19.38	-29.13	-40.48
Net Property, Plant and Equip., 2 Yr. CAGR %	141.36	128.7	4.72	7.01	-17.2
Total Assets, 2 Yr. CAGR %	161.79	82.38	29.88	37.92	13.93
Tangible Book Value, 2 Yr. CAGR %	86.43	203	-16.36	125.45	104.62
Common Equity, 2 Yr. CAGR %	89.3	256.36	-8.86	95.74	87.13
Cash From Operations, 2 Yr. CAGR %	319.65	195.72	24.82	21.54	28.8
Capital Expenditures, 2 Yr. CAGR %	176.48	140.79	-54.87	44.46	-40.99
Levered Free Cash Flow, 2 Yr. CAGR %	222.56	396.21	-10.23	76.04	134.07
Unlevered Free Cash Flow, 2 Yr. CAGR %	257.72	531.97	-9.46	76.04	134.07
Compound Annual Growth Rate Over Three Years
EBITDA, 3 Yr. CAGR %	121.44	152.4	83.88	35.64	14.33
EBITA, 3 Yr. CAGR %	120.91	149.7	83.75	35.54	14.26
EBIT, 3 Yr. CAGR %	120.91	150.98	84.98	36.09	14.21
Earnings From Cont. Operations, 3 Yr. CAGR %	139.63	155.03	96.8	14.87	11.39
Net Income, 3 Yr. CAGR %	139.63	155.03	96.8	14.87	11.39
Normalized Net Income, 3 Yr. CAGR %	139.63	155.03	96.8	14.87	11.39
Diluted EPS Before Extra, 3 Yr. CAGR %	-35.8	-29.23	65.87	-14.84	-25.68
Net Property, Plant and Equip., 3 Yr. CAGR %	122.74	67.55	92.23	-2.58	-2.35
Total Assets, 3 Yr. CAGR %	178.91	94.51	73.52	26.88	26.8
Tangible Book Value, 3 Yr. CAGR %	92.49	22.03	130.73	38.52	77.6
Common Equity, 3 Yr. CAGR %	94.46	35.97	146.83	39.04	60.66
Cash From Operations, 3 Yr. CAGR %	105.87	210.3	100.26	35.83	15.07
Capital Expenditures, 3 Yr. CAGR %	98.44	-41.44	255.58	-62.01	39.25
Levered Free Cash Flow, 3 Yr. CAGR %	-	194.97	100.36	96.81	21.53
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	217.54	135.63	97.93	21.53
Compound Annual Growth Rate Over Five Years
EBITDA, 5 Yr. CAGR %	-	-	75.06	93.64	55.34
EBITA, 5 Yr. CAGR %	-	-	74.91	92.21	55.2
EBIT, 5 Yr. CAGR %	-	-	75.61	92.69	55.63
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	83.45	80.76	55.49
Net Income, 5 Yr. CAGR %	-	-	83.45	80.76	55.49
Normalized Net Income, 5 Yr. CAGR %	-	-	83.45	80.76	55.49
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-17.72	-29.19	10.08
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	64.7	40.04	37.25
Total Assets, 5 Yr. CAGR %	-	-	105.44	69.52	46.65
Tangible Book Value, 5 Yr. CAGR %	-	-	37.91	55.99	119.91
Common Equity, 5 Yr. CAGR %	-	-	43.61	57.3	120.95
Cash From Operations, 5 Yr. CAGR %	-	-	68.53	113.28	67.85
Capital Expenditures, 5 Yr. CAGR %	-	-	9.74	-15.97	73.36
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	139.81	113.22
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	150.8	135.01